Politics & Law FLC appeal hearing postponed, former group chairman claiming life-threatening health conditions
Media-OutReach Newswire The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist